Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

IPCA Laboratories Ltd.

ClinicalTrials.gov Identifier:

NCT01618825

First received: June 11, 2012

Last updated: NA

Last verified: June 2012

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2012
Primary Completion Date:	May 2012 (Final data collection date for primary outcome measure)